SHL Telemedicine PE Ratio 2022-2023 | SHLT

Current and historical p/e ratio for SHL Telemedicine (SHLT) from 2022 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. SHL Telemedicine PE ratio as of April 26, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

SHL Telemedicine PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-26 5.55 inf
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.077B $0.057B
SHL Telemedicine Ltd is engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Its solutions for healthcare professionals include: CHF monitoring service which supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease and Readmission Solutions for reducing heart-related readmissions. SHL Telemedicine Ltd is based in Israel.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.221B 21.82
Inspire Medical Systems (INSP) United States $6.999B 0.00
IRhythm Technologies (IRTC) United States $3.463B 0.00
Axonics (AXNX) United States $3.394B 0.00
10x Genomics (TXG) United States $3.206B 0.00
Enovis (ENOV) United States $3.022B 22.96
Azenta (AZTA) United States $2.872B 234.09
Olink Holding AB (publ) (OLK) Sweden $2.869B 0.00
Hims & Hers Health (HIMS) United States $2.629B 0.00
Privia Health (PRVA) United States $2.135B 94.68
Schrodinger (SDGR) United States $1.688B 0.00
Omnicell (OMCL) United States $1.246B 30.48
Phreesia (PHR) United States $1.154B 0.00
Definitive Healthcare (DH) United States $0.793B 0.00
Standard BioTools (LAB) United States $0.685B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Talkspace (TALK) United States $0.520B 0.00
Clover Health Investments (CLOV) United States $0.332B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.323B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
American Well (AMWL) United States $0.156B 0.00
P3 Health Partners (PIII) United States $0.152B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.136B 0.00
MSP Recovery (LIFW) United States $0.131B 0.00
Outset Medical (OM) United States $0.123B 0.00
TruBridge (TBRG) United States $0.115B 4.91
111 (YI) China $0.084B 0.00
Future Health ESG (FHLT) United States $0.070B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00